Skip to search formSkip to main contentSkip to account menu

pramiracetam

Known as: N-(2-(bis(1-methylethyl)amino)ethyl)-2-oxo-1-pyrrolidineacetamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The effect of the nootropic drug pramiracetam (CI-879) on acquisition of a radial arm maze task was examined in the rat. Two… 
1994
1994
Various pharmacological strategies have been employed in the treatment of Alzheimer’s disease (AD): cholinergic enhancers… 
1992
1992
The pharmacokinetics of pramiracetam was assessed using an HPLC method after oral administration of two different formulations of… 
1990
1990
The protective effects of DM-9384 [N-(2,6-dimethylphenyl)-2-(2-oxo- 1-pyrrolidinyl) acetamide] against cerebral anoxia were… 
1989
1989
The choline transport across the blood-brain barrier was studied in nine brain regions of male Wistar rats after treatment with… 
1987
1987
High affinity choline uptake (HACU) in the hippocampus and striatal concentration of dopamine (DA) and homovanillic acid (HVA) as… 
1985
1985
The pharmacokinetics of pramiracetam, a new, investigational, cognition activator, were assessed in normal male volunteers as… 
1985
1985
The basal EEG profile of the aged Fisher-344 rat was consistently different from that of the young rat, showing dominant high…